Objective: The aim of this study was to evaluate the efficacy of low-intensity linear shockwave treatment (LI-ESWT) in patients with severe arteriogenic erectile dysfunction (ED) by comparing LI-ESWT combined with daily use of phosphodiesterase type 5 inhibitors (PDE5i) with the daily use of PDE5i alone.Materials and Methods: A total of 23 patients were included in the study.The patients were separated into two groups: LI-ESWT + tadalafil 5 mg (n=10) group and tadalafil 5 mg only group (n=13).LI-ESWT was applied once a week for four weeks.
Oral tadalafil 5 mg once a day was started and continued for three months in both groups.The patients were evaluated with the International Erectile Function Index Questionnaire Erectile Function Domain Lice (IIEF-EF), Erection Hardness Score (EHS) and Sexual Encounter Profile (SEP) 2 and 3 before treatment and the 1 and 3 months after treatment.Results: No statistically significant difference was detected among IIEF-EF scores measured before and 1 and 3 months after treatment (p=0.091, p=0.
198).At the end of the third month, IIEF score increased 4 points in LI-ESWT + tadalafil 5 mg group and 3.2 points in tadalafil 5 mg only group.No statistically significant difference was detected in EHS, and the rate of positive responses to SEP2 and SEP3 questions at the 1st and 3rd months between the groups.
Conclusion: LI-ESWT is easily applicable without any significant side effects and it has positive effects on the outcomes, however, it is not an effective treatment Bike Parts - Brakes - Pads method in patients with severe arteriogenic ED.